Cardiol Therapeutics Inc. (CRDL.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 113.96M |
| Enterprise Value | 92.66M |
| P/E Ratio | -4.82 |
| PEG Ratio | -0.13 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.94 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.9 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.16 |
| Return On Equity | -1.8 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -101,983 |
| EBITDA | -34.21M |
| Net Income | -33.82M |
| Diluted EPS | -0.39 |
Balance Sheet
| Total Cash | 26.08M |
| Total Cash/Share | 0.23 |
| Total Debt | 106,998 |
| Total Debt/Equity | 0 |
| Current Ratio | 5.55 |
| Book Value Per Share | 0.21 |
Price History
| 52-Week Change | -0.6 |
| 52-Week High | 3.23 |
| 52-Week Low | 1.23 |
| Moving Average 50 Days | 2.41 |
| Moving Average 200 Days | 1.81 |
Statistics
| Average Volume | 251,711 |
| Shares Outstanding | 120.66M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
